IBDEI1M9 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.4,757,0)
;;=PREVENTIVE MED-EST PT^4^60
;;^UTILITY(U,$J,358.4,758,0)
;;=PREVENTIVE MED-NEW PT^5^60
;;^UTILITY(U,$J,358.4,759,0)
;;=TRANSITIONAL CARE MGMT (TCM)^6^60
;;^UTILITY(U,$J,358.4,760,0)
;;=PC COMMON DIAGNOSES^1^61
;;^UTILITY(U,$J,358.4,761,0)
;;=ADMINISTRATIVE TOPICS^15^61
;;^UTILITY(U,$J,358.4,762,0)
;;=ANGINA^16^61
;;^UTILITY(U,$J,358.4,763,0)
;;=ATHEROSCLEROSIS^17^61
;;^UTILITY(U,$J,358.4,764,0)
;;=CARDIOVASCULAR^18^61
;;^UTILITY(U,$J,358.4,765,0)
;;=DERMATOLOGY^22^61
;;^UTILITY(U,$J,358.4,766,0)
;;=EAR DISORDERS^24^61
;;^UTILITY(U,$J,358.4,767,0)
;;=EENT^25^61
;;^UTILITY(U,$J,358.4,768,0)
;;=ENDOCRINE/METABOLIC^26^61
;;^UTILITY(U,$J,358.4,769,0)
;;=EYE DISORDERS^27^61
;;^UTILITY(U,$J,358.4,770,0)
;;=EYE INJURY^28^61
;;^UTILITY(U,$J,358.4,771,0)
;;=GASTROENTEROLOGY^29^61
;;^UTILITY(U,$J,358.4,772,0)
;;=GU/RENAL^30^61
;;^UTILITY(U,$J,358.4,773,0)
;;=HEADACHE^31^61
;;^UTILITY(U,$J,358.4,774,0)
;;=HEART VALVE DISEASE^32^61
;;^UTILITY(U,$J,358.4,775,0)
;;=HEMATOLOGY/ONCOLOGY^33^61
;;^UTILITY(U,$J,358.4,776,0)
;;=HISTORY OF ILLNESS^34^61
;;^UTILITY(U,$J,358.4,777,0)
;;=INFECTIOUS DISEASE^35^61
;;^UTILITY(U,$J,358.4,778,0)
;;=LIVER DISEASE^36^61
;;^UTILITY(U,$J,358.4,779,0)
;;=MENTAL HEALTH^38^61
;;^UTILITY(U,$J,358.4,780,0)
;;=MOVEMENT DISORDERS^39^61
;;^UTILITY(U,$J,358.4,781,0)
;;=MUSCULOSKELETAL^40^61
;;^UTILITY(U,$J,358.4,782,0)
;;=NEUROLOGY^41^61
;;^UTILITY(U,$J,358.4,783,0)
;;=PAIN^42^61
;;^UTILITY(U,$J,358.4,784,0)
;;=PREVENTIVE HEALTH^43^61
;;^UTILITY(U,$J,358.4,785,0)
;;=PULMONARY^44^61
;;^UTILITY(U,$J,358.4,786,0)
;;=SEXUAL TRAUMA^45^61
;;^UTILITY(U,$J,358.4,787,0)
;;=SIGNS,SYMPTOMS,CONDITIONS^46^61
;;^UTILITY(U,$J,358.4,788,0)
;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^61
;;^UTILITY(U,$J,358.4,789,0)
;;=SUBSTANCE DISORDERS^48^61
;;^UTILITY(U,$J,358.4,790,0)
;;=VARICOSE VEINS^50^61
;;^UTILITY(U,$J,358.4,791,0)
;;=WOMEN'S HEALTH^51^61
;;^UTILITY(U,$J,358.4,792,0)
;;=WOUNDS-INITIAL ENCOUNTER^52^61
;;^UTILITY(U,$J,358.4,793,0)
;;=COMA^20^61
;;^UTILITY(U,$J,358.4,794,0)
;;=CAUSES OF INJURY^19^61
;;^UTILITY(U,$J,358.4,795,0)
;;=DEMENTIA^21^61
;;^UTILITY(U,$J,358.4,796,0)
;;=LONG TERM CURRENT DRUG THERAPY^37^61
;;^UTILITY(U,$J,358.4,797,0)
;;=ACQUIRED ABSENCE OF BODY PART(S)^2^61
;;^UTILITY(U,$J,358.4,798,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^49^61
;;^UTILITY(U,$J,358.4,799,0)
;;=ACSC ACUTE KIDNEY FAILURE^3^61
;;^UTILITY(U,$J,358.4,800,0)
;;=ACSC ANGINA^4^61
;;^UTILITY(U,$J,358.4,801,0)
;;=ACSC ASTHMA/BRONCHITIS/COPD^5^61
;;^UTILITY(U,$J,358.4,802,0)
;;=ACSC CHF^6^61
;;^UTILITY(U,$J,358.4,803,0)
;;=ACSC DEHYDRATION^7^61
;;^UTILITY(U,$J,358.4,804,0)
;;=ACSC DIABETES TYPE 1^8^61
;;^UTILITY(U,$J,358.4,805,0)
;;=ACSC DIABETES TYPE 2^9^61
;;^UTILITY(U,$J,358.4,806,0)
;;=ACSC HYPERTENSION^10^61
;;^UTILITY(U,$J,358.4,807,0)
;;=ACSC INFECTIOUS GASTROENTERITIS^11^61
;;^UTILITY(U,$J,358.4,808,0)
;;=ACSC PNEUMONIA^12^61
;;^UTILITY(U,$J,358.4,809,0)
;;=ACSC UTI^13^61
;;^UTILITY(U,$J,358.4,810,0)
;;=ACSC VIRAL ENTERITIS^14^61
;;^UTILITY(U,$J,358.4,811,0)
;;=E-CIG/VAPE LUNG INJURY^23^61
;;^UTILITY(U,$J,358.4,812,0)
;;=BLOODS, ARTERIAL & VENOUS^1^62
;;^UTILITY(U,$J,358.4,813,0)
;;=OXIMETRY (WHEN ONLY SERVICE)^7^62
;;^UTILITY(U,$J,358.4,814,0)
;;=PULMONARY FUNCTION TESTING^9^62
;;^UTILITY(U,$J,358.4,815,0)
;;=THORACENTESIS^11^62
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1M9 3784 printed Sep 23, 2025@19:47:29 Page 2
IBDEI1M9 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.4)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.4,757,0)
+2 ;;=PREVENTIVE MED-EST PT^4^60
+3 ;;^UTILITY(U,$J,358.4,758,0)
+4 ;;=PREVENTIVE MED-NEW PT^5^60
+5 ;;^UTILITY(U,$J,358.4,759,0)
+6 ;;=TRANSITIONAL CARE MGMT (TCM)^6^60
+7 ;;^UTILITY(U,$J,358.4,760,0)
+8 ;;=PC COMMON DIAGNOSES^1^61
+9 ;;^UTILITY(U,$J,358.4,761,0)
+10 ;;=ADMINISTRATIVE TOPICS^15^61
+11 ;;^UTILITY(U,$J,358.4,762,0)
+12 ;;=ANGINA^16^61
+13 ;;^UTILITY(U,$J,358.4,763,0)
+14 ;;=ATHEROSCLEROSIS^17^61
+15 ;;^UTILITY(U,$J,358.4,764,0)
+16 ;;=CARDIOVASCULAR^18^61
+17 ;;^UTILITY(U,$J,358.4,765,0)
+18 ;;=DERMATOLOGY^22^61
+19 ;;^UTILITY(U,$J,358.4,766,0)
+20 ;;=EAR DISORDERS^24^61
+21 ;;^UTILITY(U,$J,358.4,767,0)
+22 ;;=EENT^25^61
+23 ;;^UTILITY(U,$J,358.4,768,0)
+24 ;;=ENDOCRINE/METABOLIC^26^61
+25 ;;^UTILITY(U,$J,358.4,769,0)
+26 ;;=EYE DISORDERS^27^61
+27 ;;^UTILITY(U,$J,358.4,770,0)
+28 ;;=EYE INJURY^28^61
+29 ;;^UTILITY(U,$J,358.4,771,0)
+30 ;;=GASTROENTEROLOGY^29^61
+31 ;;^UTILITY(U,$J,358.4,772,0)
+32 ;;=GU/RENAL^30^61
+33 ;;^UTILITY(U,$J,358.4,773,0)
+34 ;;=HEADACHE^31^61
+35 ;;^UTILITY(U,$J,358.4,774,0)
+36 ;;=HEART VALVE DISEASE^32^61
+37 ;;^UTILITY(U,$J,358.4,775,0)
+38 ;;=HEMATOLOGY/ONCOLOGY^33^61
+39 ;;^UTILITY(U,$J,358.4,776,0)
+40 ;;=HISTORY OF ILLNESS^34^61
+41 ;;^UTILITY(U,$J,358.4,777,0)
+42 ;;=INFECTIOUS DISEASE^35^61
+43 ;;^UTILITY(U,$J,358.4,778,0)
+44 ;;=LIVER DISEASE^36^61
+45 ;;^UTILITY(U,$J,358.4,779,0)
+46 ;;=MENTAL HEALTH^38^61
+47 ;;^UTILITY(U,$J,358.4,780,0)
+48 ;;=MOVEMENT DISORDERS^39^61
+49 ;;^UTILITY(U,$J,358.4,781,0)
+50 ;;=MUSCULOSKELETAL^40^61
+51 ;;^UTILITY(U,$J,358.4,782,0)
+52 ;;=NEUROLOGY^41^61
+53 ;;^UTILITY(U,$J,358.4,783,0)
+54 ;;=PAIN^42^61
+55 ;;^UTILITY(U,$J,358.4,784,0)
+56 ;;=PREVENTIVE HEALTH^43^61
+57 ;;^UTILITY(U,$J,358.4,785,0)
+58 ;;=PULMONARY^44^61
+59 ;;^UTILITY(U,$J,358.4,786,0)
+60 ;;=SEXUAL TRAUMA^45^61
+61 ;;^UTILITY(U,$J,358.4,787,0)
+62 ;;=SIGNS,SYMPTOMS,CONDITIONS^46^61
+63 ;;^UTILITY(U,$J,358.4,788,0)
+64 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^61
+65 ;;^UTILITY(U,$J,358.4,789,0)
+66 ;;=SUBSTANCE DISORDERS^48^61
+67 ;;^UTILITY(U,$J,358.4,790,0)
+68 ;;=VARICOSE VEINS^50^61
+69 ;;^UTILITY(U,$J,358.4,791,0)
+70 ;;=WOMEN'S HEALTH^51^61
+71 ;;^UTILITY(U,$J,358.4,792,0)
+72 ;;=WOUNDS-INITIAL ENCOUNTER^52^61
+73 ;;^UTILITY(U,$J,358.4,793,0)
+74 ;;=COMA^20^61
+75 ;;^UTILITY(U,$J,358.4,794,0)
+76 ;;=CAUSES OF INJURY^19^61
+77 ;;^UTILITY(U,$J,358.4,795,0)
+78 ;;=DEMENTIA^21^61
+79 ;;^UTILITY(U,$J,358.4,796,0)
+80 ;;=LONG TERM CURRENT DRUG THERAPY^37^61
+81 ;;^UTILITY(U,$J,358.4,797,0)
+82 ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^61
+83 ;;^UTILITY(U,$J,358.4,798,0)
+84 ;;=SUICIDE IDEATIONS/ATTEMPTS^49^61
+85 ;;^UTILITY(U,$J,358.4,799,0)
+86 ;;=ACSC ACUTE KIDNEY FAILURE^3^61
+87 ;;^UTILITY(U,$J,358.4,800,0)
+88 ;;=ACSC ANGINA^4^61
+89 ;;^UTILITY(U,$J,358.4,801,0)
+90 ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^61
+91 ;;^UTILITY(U,$J,358.4,802,0)
+92 ;;=ACSC CHF^6^61
+93 ;;^UTILITY(U,$J,358.4,803,0)
+94 ;;=ACSC DEHYDRATION^7^61
+95 ;;^UTILITY(U,$J,358.4,804,0)
+96 ;;=ACSC DIABETES TYPE 1^8^61
+97 ;;^UTILITY(U,$J,358.4,805,0)
+98 ;;=ACSC DIABETES TYPE 2^9^61
+99 ;;^UTILITY(U,$J,358.4,806,0)
+100 ;;=ACSC HYPERTENSION^10^61
+101 ;;^UTILITY(U,$J,358.4,807,0)
+102 ;;=ACSC INFECTIOUS GASTROENTERITIS^11^61
+103 ;;^UTILITY(U,$J,358.4,808,0)
+104 ;;=ACSC PNEUMONIA^12^61
+105 ;;^UTILITY(U,$J,358.4,809,0)
+106 ;;=ACSC UTI^13^61
+107 ;;^UTILITY(U,$J,358.4,810,0)
+108 ;;=ACSC VIRAL ENTERITIS^14^61
+109 ;;^UTILITY(U,$J,358.4,811,0)
+110 ;;=E-CIG/VAPE LUNG INJURY^23^61
+111 ;;^UTILITY(U,$J,358.4,812,0)
+112 ;;=BLOODS, ARTERIAL & VENOUS^1^62
+113 ;;^UTILITY(U,$J,358.4,813,0)
+114 ;;=OXIMETRY (WHEN ONLY SERVICE)^7^62
+115 ;;^UTILITY(U,$J,358.4,814,0)
+116 ;;=PULMONARY FUNCTION TESTING^9^62
+117 ;;^UTILITY(U,$J,358.4,815,0)
+118 ;;=THORACENTESIS^11^62
